Skip to main content

Table 3 Patients’ clinical characteristics and MSAS

From: Prediction of perioperative complications after robotic-assisted radical hysterectomy for cervical cancer using the modified surgical Apgar score

  Complication P-value
No (n = 85) Yes (n = 53)
Age (years) 44.1 (±10.1) 43.1 (±9.8) 0.51
BMI (kg/m2) 22.9 (±3.0) 22.9 (±3.3) 0.98
Underlying disease (n) 17 (20.0) 7 (13.2) 0.31
Previous pelvic surgery (n) 35 (41.2) 18 (33.7) 0.40
Surgical time (min) 190.0 (±70.9) 221.0 (±90.0) 0.026
Preoperative Hb (g/dL) 13.0 (±1.20) 12.6 (±1.3) 0.10
Postoperative Hb (g/dL) 12.8 (±1.3) 11.0 (±1.3) 0.27
NAC (n) 4 (4.7) 3 (5.8) 0.77
Surgical procedure (n)    0.47
 Radical trachelectomy (±BPLD and PALND) 12 (14.1) 9 (17.0)  
 Radical hysterectomy (±BPLD, PALND, and BSO) 73 (85.9) 44 (83.0)  
SAS 7.4 (±1.1) 7.1 (±1.3) 0.27
MSAS 7.0 (±1.2) 6.5 (±1.8) 0.047
  1. MSAS modified surgical Apgar score, BMI body mass index, Hb hemoglobulin, NAC neoadjuvant chemotherapy, BPLD bilateral pelvic lymph node dissection, PALND paraaortic lymph node dissection, BSO bilateral salpingo-oophorectomy, SAS surgical Apgar score
  2. Data are presented as means (± standard deviations) or as numbers of patients (%)